NN
Novo Nordisk's semaglutide — the active ingredient in Ozempic/Wegovy — is a 31-amino-acid peptide manufactured via recombinant DNA technology in yeast. Industrial-scale peptide chemistry reshaping metabolic medicine.
7
Novo Nordisk's semaglutide — the active ingredient in Ozempic/Wegovy — is a 31-amino-acid peptide manufactured via recombinant DNA technology in yeast. Industrial-scale peptide chemistry reshaping metabolic medicine.